User profiles for E. Stoelben
Erich StoelbenThoraxchirurgie Verified email at kliniken-koeln.de Cited by 11673 |
[HTML][HTML] Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
…, S Ansén, C Ludwig, W Engel-Riedel, E Stoelben… - Cell, 2012 - cell.com
Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, is responsible
for more than 500,000 deaths per year worldwide. Here, we report exome and genome …
for more than 500,000 deaths per year worldwide. Here, we report exome and genome …
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
…, Z Wainer, P Russell, I Petersen, Y Chen, E Stoelben… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
…, R Buettner, K Ernestus, E Stoelben… - Science translational …, 2010 - science.org
… Buettner, KE, E. Stoelben, J. Wolf, and PN contributed critical tumor specimens and contributed
to the discussion of the data. SP reviewed tumor histology, analyzed the FISH data, and …
to the discussion of the data. SP reviewed tumor histology, analyzed the FISH data, and …
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
…, H Groen, W Timens, H Sietsma, E Stoelben… - Cancer discovery, 2011 - AACR
Although genomically targeted therapies have improved outcomes for patients with lung
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…
Extracorporeal membrane oxygenation: evolving epidemiology and mortality
…, D Brodie, S Strassmann, E Stoelben… - Intensive care …, 2016 - Springer
Purpose The evolution of the epidemiology and mortality of extracorporeal membrane
oxygenation (ECMO) remains unclear. The present study investigates the evolving epidemiology …
oxygenation (ECMO) remains unclear. The present study investigates the evolving epidemiology …
Chest wall resection for lung cancer: indications and techniques
E Stoelben, C Ludwig - European journal of cardio-thoracic …, 2009 - academic.oup.com
Lung cancer invasion of the chest wall is not a common challenge and represents only about
5% of all patients resected for lung cancer. In T3N0M0 tumours, long-term survival reaches …
5% of all patients resected for lung cancer. In T3N0M0 tumours, long-term survival reaches …
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
…, A Riviere, P Koralewski, JL Breton, E Stoelben… - The lancet …, 2011 - thelancet.com
Background Chemotherapy is the standard of care for advanced stages of non-small-cell
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …
lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified …
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer
…, T Schumacher, M Mix, S Ruhland, E Stoelben… - European journal of …, 2004 - Springer
Purpose The purpose of this study was to evaluate the impact of [ 18 F]fluorodeoxy-d-glucose
positron emission tomography (FDG-PET) on the primary staging of patients with small-cell …
positron emission tomography (FDG-PET) on the primary staging of patients with small-cell …
[HTML][HTML] Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
…, M Lund-Iversen, S Ansén, E Stoelben… - Nature …, 2014 - nature.com
Pulmonary carcinoids are rare neuroendocrine tumours of the lung. The molecular alterations
underlying the pathogenesis of these tumours have not been systematically studied so far. …
underlying the pathogenesis of these tumours have not been systematically studied so far. …
CD74–NRG1 Fusions in Lung Adenocarcinoma
…, C Becker, P Nürnberg, JM Heuckmann, E Stoelben… - Cancer discovery, 2014 - AACR
We discovered a novel somatic gene fusion, CD74–NRG1, by transcriptome sequencing of
25 lung adenocarcinomas of never smokers. By screening 102 lung adenocarcinomas …
25 lung adenocarcinomas of never smokers. By screening 102 lung adenocarcinomas …